Teva Pharmaceutical Industries has decided not to launch atorvastatin, a generic version of Pfizer's Lipitor. The decision will help Ranbaxy Laboratories and Dr Reddy's Laboratories gain larger sales of the medicine in the US, the ...
Meridian Medical Technologies,a Pfizer subsidiary,and Teva have entered into a settlement agreement to resolve generic epinephrine auto-injector pending patent litigation. Under the terms of the agreement,Teva may launch a generic ...
Tags: Epinephrine Auto, Meridian, Teva, generic epinephrine auto-injector
Teva Pharmaceutical has received US Food and Drug Administration(FDA)approval for Synribo injection to treat adult patients with chronic phase(CP)or accelerated phase(AP)chronic myeloid leukemia(CML)with resistance and/or intolerance to ...
Tags: Teva Synribo Injection, US FDA, Teva Pharmaceutical, chronic phase
Teva UK, a part of Teva Pharmaceutical Industries, has announced the launch of generic Irbesartan tablets. Irbesartan, a generic version of Aprovel (Irbesartan) by Sanofi Pharma Bristol-Myers Squibb SNC, is indicated to treat essential ...
Tags: Irbesartan Tablets, antihypertensive medicinal product regimen
XTL Biopharmaceuticals has acquired 4,620,356 shares of Proteologics from Teva Pharmaceutical for nearly NIS6.5m($1.6m). The company has purchased single share at an amount of NIS1.405($0.36). The acquired shares represent all the ...
Tags: XTL Biopharmaceuticals, shares, drugs, multiple myeloma, schizophrenia
India-based Lupin's subsidiary Lupin Pharmaceuticals has received final approval for Kurvelo tablets from the US Food and Drugs Administration (FDA) to market a generic version of Teva Nordette tablets. The tablet, which is the AB-rated ...
Teva Pharmaceutical Industries has reported that the Glatiramer Acetate Low-Frequency Administration (GALA) study evaluating a new dose of glatiramer acetate injection (GA) met its primary endpoint. The Phase III trial evaluated the ...
Tags: Teva Pharmaceutical Industries, Medicine, glatiramer acetate injection
Teva UK, a generic pharmaceutical company, has introduced (Oroeze) Benzydamine 0.15% w/v Oromucosal spray. The (Oroeze) Benzydamine 0.15% w/v Oromucosal spray is available in the Teva 360 livery. The new product is a version of Difflam ...
Tags: Medicine, Benzydamine 0.15%w/v Oromucosal spray, Difflam
Ambit Biosciences and Teva Pharmaceutical Industries have announced the FDA clearance of CEP-32496, a novel BRAF (V600E) kinase inhibitor. The preclinical findings also demonstrate that CEP-32496 possesses potent and sustained anti-tumor ...
Tags: Ambit, Teva, FDA clearance